Expanscience's sustainability journey: Transformation toward a regenerative business model Custom Case Solution & Analysis

Case Evidence Brief

Financial Metrics

Annual Turnover: 324.9 million Euros in 2022.
International Presence: 77 percent of revenue generated outside France.
Subsidiaries: 14 legal entities operating globally.
Distribution: Products sold in approximately 100 countries.
Investment: 2.4 percent of turnover allocated to Research and Development.

Operational Facts

Headcount: 1161 employees worldwide as of 2022.
Manufacturing: Primary production facility located in Epernon, France, which is ISO 14001 and ISO 45001 certified.
Product Portfolio: Specialized in dermo-cosmetics via the Mustela brand and pharmaceuticals for osteoarthritis treatment.
Supply Chain: Direct sourcing of raw materials, specifically avocados and sunflowers, with significant operations in Peru.
Sustainability Status: Achieved B Corp certification in 2018 and recertified in 2021 with a score of 108.1 points.

Stakeholder Positions

Jean-Paul Berthome, CEO: Committed to transitioning the company from a traditional Corporate Social Responsibility model to a regenerative business model by 2040.
Sophie Robert-Velut, Director of the Mustela brand: Focuses on redesigning product life cycles and reducing plastic dependency.
B Lab: Provides the framework and verification for the social and environmental performance of the company.
Local Communities in Peru: Key partners in the raw material supply chain whose economic and social development is integrated into the company sourcing strategy.

Information Gaps

Specific margin impact of transitioning from high-volume plastic packaging to refillable models.
Detailed breakdown of Scope 3 emissions by individual product category.
Quantified financial risk of potential regulatory changes in the pharmaceutical sector regarding regenerative claims.

Strategic Analysis

Core Strategic Question

How can the Expanscience organization fundamentally decouple its financial growth from environmental resource consumption to achieve a regenerative status by 2040 while maintaining its competitive position in the pharmaceutical and dermo-cosmetic markets?

Structural Analysis

Value Chain Analysis: The current model relies on heavy extraction and global logistics. Transitioning to a regenerative model requires shifting from a linear take-make-waste sequence to a circular flow where product end-of-life feeds back into the production cycle.
Porter Five Forces: Competitive rivalry is high in the dermo-cosmetic space. Differentiation through sustainability is a defensive barrier against new entrants but increases the bargaining power of specialized green suppliers.
Jobs-to-be-Done: Consumers are not just buying skin care; they are seeking guilt-free health solutions. The regenerative model aligns with the evolving job of responsible parenting for the Mustela customer base.

Strategic Options

Option 1: Aggressive Portfolio Pruning. Eliminate all products that cannot meet regenerative criteria by 2030. This reduces complexity and environmental footprint but risks immediate revenue loss and market share contraction.

Option 2: Service-Based Transformation. Shift from selling units to selling skin-health services. This includes bulk dispensing stations and subscription-based refill models. It requires high capital expenditure for retail infrastructure but creates long-term customer loyalty.

Option 3: Open-Source Sustainability Leadership. Share proprietary green chemistry and supply chain innovations with competitors to drive industry-wide standards. This reduces the cost of sustainable materials through scale but erodes the unique competitive advantage of the company.

Preliminary Recommendation

Pursue Option 2 combined with targeted elements of Option 3. The company must lead the transition to a service-based model to protect margins while collaborating on industry standards to lower the systemic costs of regenerative raw materials. This path balances financial viability with the 2040 regenerative goal.

Implementation Roadmap

Critical Path

Phase 1 (Months 1-12): Conduct a comprehensive audit of the product portfolio against the 2040 regenerative criteria. Identify high-impact products for immediate redesign or phase-out.
Phase 2 (Months 13-24): Scale the bulk and refill pilot programs across European markets. Secure partnerships with major retail chains to install necessary infrastructure.
Phase 3 (Months 25-36): Redesign the Peruvian supply chain to move beyond sustainable sourcing toward active biodiversity restoration.

Key Constraints

Consumer Behavior: The transition to refillable models depends on customers changing their purchasing habits. If convenience remains the primary driver, adoption will stall.
Regulatory Barriers: Pharmaceutical and cosmetic regulations vary by country, often complicating the use of bulk dispensers for regulated products.

Risk-Adjusted Implementation Strategy

The strategy includes a 15 percent contingency buffer in the R and D budget to account for unforeseen technical challenges in biodegradable packaging. Implementation will follow a tiered rollout, starting with the most environmentally conscious markets in Northern Europe before expanding to regions with less developed sustainability infrastructure.

Executive Review and BLUF

BLUF

The Expanscience organization must commit to a radical redesign of its business model to meet its 2040 regenerative goal. The current trajectory of incremental improvement is insufficient. The company should prioritize the transition from a product-centric model to a service-and-refill model. This shift will require significant upfront investment and a temporary reduction in margins but is the only path to long-term viability in a carbon-constrained economy. Success depends on the ability to influence consumer behavior and industry regulations simultaneously.

Dangerous Assumption

The single most consequential premise is that consumers will accept the inconvenience of refillable and circular systems without a significant price discount. If the market continues to prioritize convenience over sustainability, the capital-intensive infrastructure for refills will become a stranded asset.

Unaddressed Risks

Supply Chain Concentration: Heavy reliance on specific regions like Peru for raw materials exposes the company to localized climate shocks and political instability. Probability: High. Consequence: Severe disruption of production.
Competitor Greenwashing: Larger competitors with greater marketing budgets may co-opt regenerative language without making substantive changes, confusing consumers and diluting the premium position of the company. Probability: High. Consequence: Erosion of brand equity.

Unconsidered Alternative

The analysis did not fully explore a localized manufacturing strategy. Instead of a centralized plant in France, the company could establish regional micro-factories closer to raw material sources and end consumers. This would drastically reduce transport emissions and increase resilience against global supply chain shocks.